Reply
Elisabeth Krones, Wolfgang Erwa, Michael Trauner, Peter Fickert – 30 April 2015
Elisabeth Krones, Wolfgang Erwa, Michael Trauner, Peter Fickert – 30 April 2015
Palak J. Trivedi, Chris J. Weston, Gwilym J. Webb, Philip N. Newsome, Gideon M. Hirschfield, David H. Adams – 30 April 2015
Che C. Colpitts, Mirjam B. Zeisel, Thomas F. Baumert – 30 April 2015
Edoardo G. Giannini, R. Todd Stravitz, Stephen H. Caldwell – 30 April 2015
Shengmei Zhou, Paula M. Hertel, Milton J. Finegold, Larry Wang, Nanda Kerkar, Jing Wang, Lee‐Jun C. Wong, Sharon E. Plon, Melissa Sambrotta, Pierre Foskett, Zhiyv Niu, Richard J. Thompson, A.S. Knisely – 29 April 2015
Satoru Hagiwara, Naoshi Nishida, Ah‐Mee Park, Toshiharu Sakurai, Akira Kawada, Masatoshi Kudo – 29 April 2015
Satoru Hagiwara, Naoshi Nishida, Ah‐Mee Park, Toshiharu Sakurai, Akira Kawada, Masatoshi Kudo – 29 April 2015
Shengmei Zhou, Paula M. Hertel, Milton J. Finegold, Larry Wang, Nanda Kerkar, Jing Wang, Lee‐Jun C. Wong, Sharon E. Plon, Melissa Sambrotta, Pierre Foskett, Zhiyv Niu, Richard J. Thompson, A.S. Knisely – 29 April 2015
Shanshan Wan, Ning Kuo, Ilona Kryczek, Weiping Zou, Theodore H. Welling – 24 April 2015 – Hepatocellular carcinoma (HCC) is highly associated with inflammation. Myeloid cells, including tumor‐associated macrophages and myeloid‐derived suppressor cells, are abundant in the HCC microenvironment and are often associated with poor prognosis. Myeloid cells in HCC play a vital role in supporting tumor initiation, progression, angiogenesis, metastasis, and therapeutic resistance.
Guangqin Xiao, Jia Shen, Lunan Yan – 24 April 2015